A plain language summary of two trials for larotrectinib in people with TRK fusion-positive lung cancer to learn how well the drug works and how safe it is

本文以通俗易懂的语言总结了两项针对TRK融合阳性肺癌患者的拉罗替尼试验，旨在了解该药物的疗效和安全性。